Neuraptive Therapeutics Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $5M

  • Investors
  • 6

Neuraptive Therapeutics General Information

Description

Developer of a therapeutic technology designed to improve the speed and quality of recovery from peripheral nerve injury. The company creates a suite of microsurgical instruments for peripheral nerve surgery after trauma or during face and body reconstructive procedures, enabling patients to rapidly recover their damaged peripheral nerve injuries and reduce their pain.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 851 Duportail Road
  • Suite 200
  • Chesterbrook, PA 19087
  • United States
+1 (484)
Primary Industry
Surgical Devices
Other Industries
Biotechnology
Drug Delivery
Vertical(s)
Corporate Office
  • 851 Duportail Road
  • Suite 200
  • Chesterbrook, PA 19087
  • United States
+1 (484)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Neuraptive Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Grant $5M Completed Clinical Trials - Phase 3
5. Debt - General 28-Aug-2024 Completed Clinical Trials - General
4. Later Stage VC (Series B) 14-Oct-2022 Completed Clinical Trials - General
3. Early Stage VC (Series A) 19-Dec-2018 Completed Clinical Trials - General
2. Seed Round 06-Sep-2017 $1M $1M Completed Clinical Trials - General
1. University Spin-Out 01-Jan-2016 Completed Pre-Clinical Trials
To view Neuraptive Therapeutics’s complete valuation and funding history, request access »

Neuraptive Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A
To view Neuraptive Therapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Neuraptive Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a therapeutic technology designed to improve the speed and quality of recovery from peripheral nerve injury
Surgical Devices
Chesterbrook, PA
6 As of 2026

Alachua, FL
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Neuraptive Therapeutics Competitors (1)

One of Neuraptive Therapeutics’s competitors is Axogen, a Formerly VC-backed company based in Alachua, FL.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Axogen Formerly VC-backed Alachua, FL
You’re viewing 1 of 1 competitors. Get the full list »

Neuraptive Therapeutics Patents

Neuraptive Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2025206224-A1 Method of treating nerve injuries Pending 05-Jan-2024
EP-4836791-A1 Method of treating nerve injuries Pending 05-Jan-2024
WO-2025147536-A1 Method of treating nerve injuries Inactive 05-Jan-2024
AU-2018308115-A1 Device and method of creating a fluid containment field for administering therapeutics to a nerve Active 26-Jul-2017
AU-2018308115-B2 Device and method of creating a fluid containment field for administering therapeutics to a nerve Active 26-Jul-2017 A61F2/02
To view Neuraptive Therapeutics’s complete patent history, request access »

Neuraptive Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Neuraptive Therapeutics Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Denniston Family Office Family Office Minority
Keiretsu Forum Angel Group Minority
Ben Franklin Technology Partners of Southeastern Pennsylvania Accelerator/Incubator Minority
Central Texas Angel Network Angel Group Minority
New Rhein Healthcare Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

Neuraptive Therapeutics FAQs

  • When was Neuraptive Therapeutics founded?

    Neuraptive Therapeutics was founded in 2016.

  • Where is Neuraptive Therapeutics headquartered?

    Neuraptive Therapeutics is headquartered in Chesterbrook, PA.

  • What is the size of Neuraptive Therapeutics?

    Neuraptive Therapeutics has 6 total employees.

  • What industry is Neuraptive Therapeutics in?

    Neuraptive Therapeutics’s primary industry is Surgical Devices.

  • Is Neuraptive Therapeutics a private or public company?

    Neuraptive Therapeutics is a Private company.

  • What is Neuraptive Therapeutics’s current revenue?

    The current revenue for Neuraptive Therapeutics is .

  • How much funding has Neuraptive Therapeutics raised over time?

    Neuraptive Therapeutics has raised $38M.

  • Who are Neuraptive Therapeutics’s investors?

    Denniston Family Office, Keiretsu Forum, Ben Franklin Technology Partners of Southeastern Pennsylvania, Central Texas Angel Network, and New Rhein Healthcare are 5 of 6 investors who have invested in Neuraptive Therapeutics.

  • Who are Neuraptive Therapeutics’s competitors?

    Axogen is a competitor of Neuraptive Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process